SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

Tag: Critical Care Medicine

Tag Search

visual bubble
visual bubble
visual bubble
visual bubble

SCCM Pod-464 CCM: More Communication: Who Needs it? Families Do!

Written communication, as a supplement to traditional verbal communication, may overcome some of the challenges that clinicians face when engaging with families in the ICU. Learn more in this discussion of the Critical Care Medicine article “Daily Written Care Summaries for Families of Critically Ill Patients: A Randomized Controlled Trial." This podcast is sponsored by Sound Physicians.


SCCM Pod-463 CCM: Clazakizumab for COVID-19: Friend or Foe?

Clazakizumab is a monoclonal antibody against human interleukin-6 that may benefit patients hospitalized with severe or critical COVID-19 accompanied by hyperinflammation. Although not yet FDA approved, clinical trials are underway worldwide. Samantha Gambles Farr, MSN, NP-C, CCRN, RNFA, is joined by Bonnie E. Lonze, MD, PhD, to discuss the article, “A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation.”


SCCM Pod-458 CCM: Association of Catecholamine in Patients With Septic Shock

Catecholamine is used in patients with septic shock to augment hemodynamics and achieve goal mean arterial pressure. Ludwig H. Lin, MD, is joined by Gretchen L. Sacha BCCCP, PharmD, to discuss this retrospective observational study to evaluate the associations of catecholamine dose, lactate concentration, and timing from shock onset at vasopressin initiation with in-hospital mortality. This podcast is sponsored by Sound Physicians.


SCCM Pod-446 Comparison of Bivalirudin Versus Heparin

This webcast will be a comparative analysis of conventional heparin- versus bivalirudin-based systemic anticoagulation in adult and pediatric patients supported on ECMO.


SCCM Pod-440 Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of ARDS

Two previously published trials presented equivocal evidence on the effect of neuromuscular blocking agent infusions in patients with acute respiratory distress syndrome. Host Kyle B. Enfield, MD, FCCM, is joined by Matthias Eikermann, MD, to discuss the different sedation regimens between these two trials, different regimens within the ROSE trial between treatment and control groups, and the hypothesis that the proportion of deeper sedation is a mediator of the effect of neuromuscular blocking agent infusions on mortality.


SCCM Pod-439 The Association Between Antibiotic Delay and Hospital Mortality

Explore the correlation between antibiotic delay and hospital mortality in patients with sepsis in this podcast.


Journal Club: Critical Care Medicine

Explore articles from the Society's leading critical care journals in this webcast series.